G Medical Innovations Holdings Ltd (GMVDF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 27, 2025, 8:00 PM EDT
GMVDF Revenue
In the year 2022, G Medical Innovations Holdings had annual revenue of $4.42M, down -10.91%. G Medical Innovations Holdings had revenue of $2.20M in the half year ending December 31, 2022, a decrease of -24.01%.
Revenue
4.42M
Revenue Growth
-10.91%
P/S Ratio
0.01
Revenue / Employee
52.62K
Employees
84
Market Cap
26.44K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 4.42M | -541.00K | -10.91% |
| Dec 31, 2021 | 4.96M | 61.00K | 1.24% |
| Dec 31, 2020 | 4.90M | -626.00K | -11.33% |
| Dec 31, 2019 | 5.53M | 2.46M | 80.47% |
| Dec 31, 2018 | 3.06M | 2.95M | 2,709.17% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |